Unlike my typical foray into these 60+ percent biotech tumblers, I actually completed some due diligence on ALIM, which I'd never heard of before. Bottom line: This is, at least on the front side, the best bet I've placed in over a year-and I have "won" on well over half of my "dangerous" spec plays. Only wish I still had MELA, OREX, ARNA, JAZZ, MDVN, etc. If you are not already invested in them, you might want to check out EXEL, HGSI, NVAX, AMED, HCA, BIOD, NPSP, SQNM, and TRGT. Disclosure: I have small positions in all of the above, except AMED and HCA which were recently sold at 10-25% profits.